Is there any possibility that something fishy went on with the Prurisol 2B trial? How could it have flopped so badly with such compelling 2A data? I thought we had a viable drug based just off the mild beneficial effects of Prurisol in an oral form with no side effects.

Stellar preclinical data.
Great PK data.
Ok 2A data.
2b total flop.

The whole situation doesnt sit well with me.